968 related articles for article (PubMed ID: 21070361)
1. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok AS
J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
[TBL] [Abstract][Full Text] [Related]
2. Does antiviral therapy prevent hepatocellular carcinoma?
Kwon H; Lok AS
Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
4. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.
Lu T; Seto WK; Zhu RX; Lai CL; Yuen MF
World J Gastroenterol; 2013 Dec; 19(47):8887-94. PubMed ID: 24379612
[TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
Pár A
Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic viruses and hepatocellular carcinoma.
Ben Ari Z; Weitzman E; Safran M
Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
Ueno Y; Sollano JD; Farrell GC
J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
[TBL] [Abstract][Full Text] [Related]
10. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy.
Halegoua-De Marzio D; Hann HW
Minerva Gastroenterol Dietol; 2014 Sep; 60(3):191-200. PubMed ID: 25000955
[TBL] [Abstract][Full Text] [Related]
12. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.
Liu CJ; Chu YT; Shau WY; Kuo RN; Chen PJ; Lai MS
Gut; 2014 Mar; 63(3):506-14. PubMed ID: 23676440
[TBL] [Abstract][Full Text] [Related]
14. [History and presence of hepatitis B and C therapy].
Husa P
Vnitr Lek; 2017; 63(7-8):465-470. PubMed ID: 28933169
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination.
Kim MN; Han KH; Ahn SH
Semin Oncol; 2015 Apr; 42(2):316-28. PubMed ID: 25843736
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
17. Role of antiviral therapy in the management of hepatocellular carcinoma.
Guan YS; He Q
Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
[TBL] [Abstract][Full Text] [Related]
18. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
Triolo M; Della Corte C; Colombo M
Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: paradigm of preventive oncology.
O'Brien TR; Kirk G; Zhang M
Cancer J; 2004; 10(2):67-73. PubMed ID: 15130266
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.
Tawada A; Kanda T; Imazeki F; Yokosuka O
Hepatol Int; 2016 Jul; 10(4):574-93. PubMed ID: 27026375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
